CHANGE IN SHAREHOLDING
CellSAf awaits Icasa decision on Cell C recapitalisation deal
Cell C’s empowerment investor, CellSAf, said on Thursday it was still waiting for the Independent Communications Authority of SA (Icasa) to tackle its concerns about the mobile network operator’s recapitalisation deal. Blue Label and Net1 recently bought 45% and 15% stakes in Cell C, respectively, in a move that was hailed as a lifeline for the indebted company. Icasa said last week its investigations into the deal found that Cell C followed the correct process in notifying regulators of a change in shareholding and that the deal did not amount to a transfer of control. However, it was still considering other complaints lodged by CellSAf, according to a letter from the regulator seen by Business Day. Blue Label said Icasa had confirmed Cell C "has complied with all applicable regulations". "The recapitalisation of Cell C has been hugely successful in that it promotes the interests of the economy, the telecommunications industry and the consumer," Blue Label said. But CellSAf said Ic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.